449 related articles for article (PubMed ID: 31830809)
1. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
2. Cell-Selective Adeno-Associated Virus-Mediated
Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
[TBL] [Abstract][Full Text] [Related]
3. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G
Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317
[TBL] [Abstract][Full Text] [Related]
4. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
5. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).
Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C
Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259
[TBL] [Abstract][Full Text] [Related]
6. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
[TBL] [Abstract][Full Text] [Related]
8. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
[TBL] [Abstract][Full Text] [Related]
9. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
[TBL] [Abstract][Full Text] [Related]
10. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
13. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
[TBL] [Abstract][Full Text] [Related]
14. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
[TBL] [Abstract][Full Text] [Related]
15. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
Liebergall SR; Goldberg EM
J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
[TBL] [Abstract][Full Text] [Related]
16. VIP interneuron impairment promotes in vivo circuit dysfunction and autism-related behaviors in Dravet syndrome.
Goff KM; Liebergall SR; Jiang E; Somarowthu A; Goldberg EM
Cell Rep; 2023 Jun; 42(6):112628. PubMed ID: 37310860
[TBL] [Abstract][Full Text] [Related]
17. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
18. Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome.
Yuan Y; O'Malley HA; Smaldino MA; Bouza AA; Hull JM; Isom LL
Sci Rep; 2019 Apr; 9(1):6210. PubMed ID: 30996233
[TBL] [Abstract][Full Text] [Related]
19. Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function.
Di Berardino C; Mainardi M; Brusco S; Benvenuto E; Broccoli V; Colasante G
Brain; 2024 Apr; 147(4):1216-1230. PubMed ID: 37812819
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.
Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL
Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]